Maven Clinic stock

Private-market facts for current and former Maven Clinic employees researching their stock.

Latest Round
Series E
Valuation
$2B
Founded
2014
Headquarters
New York, NY
Founders
Kate Ryder
Status
private

Talk to a Maven Clinic stock specialist

Get personalized guidance on your Maven Clinic shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Maven Clinic is a virtual clinic for women's and family health, providing telehealth care management for fertility, maternity, parenting, and menopause.

Maven Clinic outlook

Equity outlook100% data confidence
1x
Base scenario
2x
Upside scenario

For employees evaluating Maven Clinic equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Maven Clinic shares

Why shareholders consider selling

Shareholders in Maven Clinic may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Maven Clinic does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Maven Clinic stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Maven Clinic shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Maven Clinic shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series E round and its reported $2B valuation can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

  • The type of security held (common shares, preferred, options, RSUs)
  • Whether the equity is fully vested and, for options, whether it has been exercised
  • Any transfer restrictions, lock-up provisions, or company approval requirements
  • Estimated net proceeds after applicable taxes and transaction fees
  • Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Maven Clinic shareholders

Exploring equity in Maven Clinic often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Maven Clinic most recently raised a Series E round in January 2024. The company was valued at $2B. Total funding raised to date is approximately $300M.

Lead investors in this round include Sequoia Capital and Oak HC/FT.

Founders & company background

Maven Clinic was founded in 2014 by Kate Ryder and is headquartered in New York, NY.

Investors

Industry

Similar private companies

Latest Maven Clinic news

Talk to a Maven Clinic stock specialist

Get personalized guidance on your Maven Clinic shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Maven Clinic still a private company?
Yes, Maven Clinic is currently a private company.
What is Maven Clinic's latest funding round?
Maven Clinic's most recent known round is Series E, raised in January 2024.
What is Maven Clinic's valuation?
Maven Clinic's latest reported valuation is $2B.
Who are the investors in Maven Clinic?
Notable investors include Sequoia Capital, Oak HC/FT, Dragoneer Investment Group, General Catalyst.
Can I sell my Maven Clinic stock?
Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Maven Clinic stock can help you evaluate your options.

Related pages

Last verified: 2026-04-13 · Maven Clinic data compiled from funding disclosures, investor announcements, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.